<DOC>
	<DOCNO>NCT00220129</DOCNO>
	<brief_summary>This study investigate efficacy safety epirubicin , cisplatin capecitabine ( ECX ) neoadjuvant therapy prior radical chemoradiotherapy use capecitabine cisplatin radio-sensitisers patient newly diagnose localize squamous cell carcinoma oesophagus .</brief_summary>
	<brief_title>Neoadjuvant Epirubicin , Cisplatin Capecitabine ( ECX ) Followed Definitive Chemoradiation With/Without Surgery Squamous Cell Carcinoma Oesophagus</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Age &gt; 18 year . Histologically verified squamous cell carcinoma cervical thoracic oesophagus American Joint Committee Cancer ( AJCC ) Stage IIII ( T13 N01 M0 ) ( 33 ) , assessed spiral multislice compute tomography ( CT ) endoscopic ultrasound , radical chemoradiation would consider curative intent . No previous chemotherapy , radiotherapy investigational drug treatment indication . World Health Organization ( WHO ) performance status 0,1 2 . Adequate bone marrow function platelet &gt; 100 x 10^9/l ; white blood cell ( WBC ) &gt; 3 x 10^9/l ; neutrophil &gt; 1.5 x 10^9/l time study entry . Serum bilirubin &lt; 35 micromol/l . Serum creatinine &lt; 180 micromol/l measure creatinine clearance 60 ml/min . No concurrent uncontrolled medical condition . No previous malignant disease nonmelanotic skin cancer carcinoma situ uterine cervix last 10 year . Life expectancy &gt; 3 month . Adequate contraceptive precaution relevant . Informed write consent . The presence locally advance metastatic disease preclude curative chemoradiation ( T4 Stage IV M1ab ) disease encompassable radical radiotherapy field . Total dysphagia ( O'Rourke 's swallow function score system 5 ) preclude swallow capecitabine even crush . Medical psychiatric condition compromise patient 's ability give inform consent . Intracerebral metastasis meningeal carcinomatosis . New York Heart Association classification Grade III IV . Uncontrolled angina pectoris . Pregnancy breast feed . Impaired renal function measure creatinine clearance le 60 ml/min . Previous investigational study drug Known malabsorption syndromes Patients know hypersensitivity fluorouracil ( 5FU ) dihydropyrimidine dehydrogenase ( DPD ) deficiency Hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>